- Single-blind multicenter randomized trial at 10 French tertiary centers enrolled 172 adults undergoing elective cardiac surgery with cardiopulmonary bypass; stopped early by the data and safety monitoring board.
- Individualized MAP targeting (within ±10% of preoperative baseline, intraoperatively and for 24 hours postoperatively) was compared with a standard target MAP of at least 65 mm Hg.
- The primary composite occurred in 32% versus 29% (relative risk 1.1; 95% CI 0.7 to 1.8; P=0.76), while hemorrhagic complications were 18% versus 3% (P=0.003).
- The authors could not determine whether individualized MAP reduced major postoperative complications and flagged the increased bleeding as a safety signal for future studies.
Cardiac
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Randomized, double-blind, placebo-controlled single-center trial of 70 patients undergoing on-pump CABG.
- Patients received intranasal dexmedetomidine 1 μg/kg or saline on the night before surgery and again 30 minutes before induction.
- At 24 hours, estimated marginal mean hs-cTnT was 170.29 vs 357.29 ng/L (P < 0.001) favoring dexmedetomidine; CK-MB was also lower.
- Sleep quality scores were higher and postoperative delirium was lower (14.3% vs 37.1%; P = 0.029), but the authors call the findings preliminary.
AI summary not available. Read the source abstract on PubMed.
- Single-center, single-blind randomized trial in a French cardiac surgery center enrolling 128 adults undergoing elective cardiac surgery with cardiopulmonary bypass, 126 analyzed.
- Patients received bilateral ultrasound-guided deep parasternal intercostal plane blocks with 40 mL ropivacaine versus standard care.
- The primary outcome, Quality of Recovery-15 at 24 hours, did not differ significantly (mean difference 3.9 points, 95% CI -3.3 to 11.2; p = 0.230), though resting pain was lower with the block at hours 2, 6, and 48.
- The authors conclude the block did not improve 24-hour recovery in mixed patients, and a non-prespecified subgroup analysis in internal mammary artery harvesting patients (n = 71) suggested possible benefit needing confirmation.
- Single-center, prospective cluster-randomized trial by month in cardiac surgery patients receiving intraoperative cryoprecipitate, stopped early at 170 of 502 planned patients.
- Pathogen-reduced cryoprecipitated fibrinogen complex (PR CRYO, storable at room temperature post-thaw) was compared with conventional cryoprecipitate (Cryo).
- Total blood components transfused were identical (6 units, IQR 3-12, p > 0.9), while PR CRYO was issued 19 min faster (12 vs. 31 min, p < 0.001) and transfusion began 16 min sooner (46 vs. 62 min, p = 0.008).
- No reduction in 30-day transfusions was shown, adverse events and 3-day transfusions were similar, and equivalence could not be formally concluded.
- This prospective randomized trial enrolled 271 adults undergoing elective sternotomy at a single center, randomized 1:1:1 to standard therapy, ESP block, or SPIP block.
- Both fascial plane blocks were added to a multimodal analgesic regimen and compared with the control group receiving standard therapy alone.
- Opioid use did not differ significantly on postoperative days 0 to 2; a day 3 difference favored ESP (p = 0.047). Maximum pain scores were lower in both block groups on days 0 to 3 (POD 1 p < 0.001, POD 2 p < 0.001, POD 3 p = 0.002).
- The authors conclude that patients undergoing sternotomy may benefit from adding either ESP or SPIP blocks to a multimodal postoperative regimen.
- Single-center, blinded-assessor randomized trial of 76 adults undergoing elective open cardiac surgery via median sternotomy.
- Bilateral serratus posterior superior intercostal plane block (SPSIPB) was compared with bilateral parasternal plane block plus chest drain-site infiltration (PSIPB), both performed preoperatively under ultrasound guidance.
- Cumulative 24-hour opioid consumption was lower with SPSIPB (mean difference 20.1 MME, 95% CI 11.7-28.5; p < 0.001) in the 33 and 31 patients analyzed.
- The authors report higher 24-hour QoR-15 scores with SPSIPB (median difference 10 points, 95% CI 6-15), above the 6-point minimal clinically important difference, with no difference in adverse events.
- Randomized controlled trial of 172 patients after elective CABG or valve surgery, allocated to five noninvasive ventilation or high-flow interfaces versus physiotherapy alone in one tertiary ICU.
- Compared a conventional oronasal mask, conventional full-face mask, Wolf Mask, ELMO helmet CPAP, and high-flow nasal cannula, each given three 60-minute daily sessions alongside standard physiotherapy.
- The Wolf Mask had the highest comfort score (9.41 ± 0.68 on a 0-10 VAS) and lowest inspiratory pressure support (5.62 ± 2.08 cmH₂O); interface comfort predicted mobilization progression (p = 0.004).
- The authors conclude full-face interfaces are associated with greater comfort, and they describe the pulmonary and oxygenation findings as exploratory and hypothesis-generating, requiring multicenter confirmation.
- A preplanned secondary analysis of a single-center, double-blind, 3-arm randomized trial in 34 adults undergoing elective CABG with cardiopulmonary bypass.
- Patients received albumin-based, gelofusine-based, or retrograde autologous priming (reference), with Stewart acid-base variables measured at five perioperative time points.
- Bypass initiation caused metabolic acidosis (-0.1 pH, -4.3 mmol/L standard base excess, -6.6 mEq/L effective strong ion difference), and these measures did not differ among priming strategies.
- Each extra liter of crystalloid independently lowered pH (-0.011; p = 0.035) and effective strong ion difference (-1.03 mEq/L; p = 0.025), which the authors attribute to crystalloid load rather than colloid choice.
- Prospective, open-label randomized trial of 105 adults aged 60 or older with moderate renal insufficiency undergoing elective OPCAB, split equally into three groups.
- Dexmedetomidine 0.4 μg/kg/h without a loading dose and dopamine 3 μg/kg/min were each compared with a normal saline control, infused from induction through 24 postoperative hours.
- Dexmedetomidine raised urine output (p < 0.01) and eGFR (p < 0.0001) versus dopamine and control at days 1 and 2; creatinine and BUN differences were not clinically significant.
- No group developed AKI by AKIN criteria, adverse events were similar across groups (p = 0.31), and the authors conclude neither drug prevented AKI beyond control.
- International, double-blind, placebo-controlled randomised trial of 955 adults with anaemia awaiting elective cardiac surgery, across 33 hospitals in 10 countries.
- Participants were randomised to 1000 mg intravenous iron or placebo 1 to 26 weeks before surgery.
- Days alive and at home at 90 days were 81.1 with iron versus 80.0 with placebo (adjusted median difference 1.0 day, 95.4% CI 0.0 to 2.1, P=0.041).
- Transfusion during hospital stay was 61.1% with iron versus 68.2% with placebo (RR 0.90, 95% CI 0.82 to 0.99, P=0.027); complications and stay did not differ.
- Prespecified substudy of a single-center randomized trial in 134 randomized adults aged ≥50 undergoing elective CABG and/or valve surgery; 116 completed 3-month follow-up.
- Compared 4-6 weeks of multimodal prehabilitation (exercise, nutritional, and psychological support) with standard preoperative care, with POCD defined by tests 1.5 SD below norms.
- POCD occurred in 28% with prehabilitation vs 22% controls (OR 1.37, 95% CI 0.54-3.50, P = 0.52); preoperative cognitive impairment was strongly associated (OR 13.28).
- Authors conclude prehabilitation did not reduce POCD at 3 months, while higher postoperative physical activity was linked to lower odds (OR 0.97, 95% CI 0.95-1.00, P = 0.047).
- Randomized, placebo-controlled, blinded trial of 120 adults undergoing elective CABG or heart valve replacement.
- Repeated ropivacaine versus saline boluses through bilateral deep parasternal intercostal plane catheters for 72 hours postoperatively.
- Pain trajectories did not differ between groups (group × time P = .77 at rest; P = 1.00 with movement), and opioid consumption showed no significant difference.
- Postoperative nausea and vomiting was more frequent with ropivacaine (46.7% vs 30%), especially in valve patients (60.6% vs 26.5%, P = .012), and the authors advise against routine use.
- Randomized, open-label trial of 88 adults with new post-CPB right ventricular systolic dysfunction (TAPSE ≤17 mm) at a tertiary cardiac surgery center.
- Milrinone, given with a loading dose and then an infusion, was compared with a dobutamine infusion.
- TAPSE improved in both groups, and milrinone's adjusted 24-hour TAPSE advantage was 1.82 mm (95% CI 0.72-2.92, p = 0.001), of uncertain clinical significance.
- Milrinone required more norepinephrine (93.2% vs 72.7%, p = 0.021), and an exploratory subgroup with PASP >40 mmHg (n = 30) suggested greater TAPSE gain, a hypothesis-generating finding.
- Randomized parallel-group trial in 36 adults undergoing cardiac surgery with cardiopulmonary bypass at a university hospital.
- Compared a normal remimazolam infusion of 1 mg/kg/h with a low-dose group whose infusion was cut to 0.7 mg/kg/h at bypass initiation.
- Free remimazolam rose over time in the normal-dose group but stayed stable in the low-dose group (time-by-group interaction p = 0.001); the largest adjusted difference was 89 ng/mL (95% CI 58-120) at 30 minutes after bypass termination.
- Free concentrations increased under constant infusion without matching bispectral index changes, and no linear association was found between BIS and drug concentrations.
- Multicenter randomized trial at two Chinese hospitals enrolled 253 patients aged 60 or older undergoing non-cardiac surgery, randomized 1:1.
- Patients were assigned to POTTS-guided transfusion, a score built from adrenaline use, FiO2, temperature and angina history, or to control care following the 2012 AABB guideline.
- Transfusion was required in 24.00% (30/125) of POTTS patients versus 35.94% (46/128) of controls (p = 0.038), with no significant difference in transfusion volume.
- The authors concluded POTTS reduced the proportion transfused without increasing complications, though complication rates were 12.80% versus 8.59% (p = 0.279), not significantly different.
- Prospective, single-center, randomized controlled trial of 60 adults undergoing elective VATS, split 30 per group.
- Ultrasound-guided serratus posterior superior intercostal plane block was compared with thoracic paravertebral block, each using 30 mL of 0.25% bupivacaine before induction.
- 24-hour opioid consumption did not differ between groups (66.8 ± 29.4 mg vs 77.2 ± 40.0 mg; mean difference -10.4 mg; 95% CI -36.1 to 15.3; p = 0.439).
- Pain scores and opioid-related adverse effects were similar at all time points, and the authors suggest the serratus block may be an effective alternative given its simpler application.
- Open-label, multicentre randomised pilot at three tertiary cardiac surgery centres, enrolling 149 low-risk adults undergoing CABG, valve or aortic surgery.
- Patients were randomised to a pulmonary artery catheter (n=76) or a central venous catheter (n=73), inserted immediately before surgery.
- Protocol compliance was 147 patients (99%) receiving the allocated catheter, and data were complete for 144 (97%).
- Median days alive and at home at 30 days were 23.7 versus 22.9, and acute kidney injury occurred in 34% versus 19%; the authors conclude a full trial is feasible.
- Single-center, double-blinded randomized trial of 72 children under 14 undergoing elective cardiac surgery with cardiopulmonary bypass in India.
- Individualized heparin dosing from a dose-response curve, after a 100 IU/kg test dose, was compared with standard 400 IU/kg weight-based dosing.
- First-pass ACT of at least 480 seconds was reached in 72.2% of the dose-response group versus 83.3% of controls (p = 0.396), so superior attainment was not shown.
- The dose-response group used less heparin (260 vs 420 IU/kg, p < 0.001) and protamine, with lower 24-hour blood loss and transfusion, though the authors caution that ACT is an imperfect surrogate.
- Secondary analysis of the FIBRES randomized trial, including 735 adults with significant postbypass bleeding and hypofibrinogenemia across eleven Canadian hospitals.
- Fibrinogen concentrate (4 g) was compared with cryoprecipitate (10 units), dosed within 24 hours after cardiopulmonary bypass as needed.
- In non-critically ill patients, FC led to fewer cumulative blood components (mean ratio 0.84, 95% CI 0.73 to 0.96; p=0.01), with a similar pattern in elective surgery patients.
- In elective surgery patients, adverse events (RR 0.85) and serious adverse events (RR 0.71) were less frequent with FC, which the authors suggest may be a safety advantage.
- Single-center randomized trial of 70 children aged 3 to 17 recovering from cardiac catheterization or electrophysiology procedures for congenital heart disease.
- Weighted blankets were compared with standard postprocedure care, with 31 patients in the blanket group and 39 age-matched controls.
- RASS scores and postprocedure sedative use did not differ between groups, so the primary efficacy aim was not met.
- Vital signs did not differ and no adverse events were linked to blanket use, leading the authors to call blankets safe and a possible low-cost nonpharmacologic option.
- This double-blind randomized trial enrolled 240 adults undergoing open heart surgery via sternotomy who had bilateral indwelling erector spinae catheters, at one large academic hospital.
- Participants were randomized to programmed intermittent boluses or continuous infusion of ropivacaine 0.2% through an electronic pump.
- The primary outcome, 72-hour opioid consumption in OMME, did not differ significantly: 1.08-fold greater with boluses (95% CI, 0.90-1.31; p = 0.40).
- No secondary outcomes differed significantly, and the authors concluded that intermittent boluses did not reduce early opioid use compared with continuous infusion.
- Prospective randomized paired-kidney study at one tertiary center, with 40 recipients from 20 brain-dead donor pairs.
- Recipients were randomized to FloTrac-guided goal-directed therapy targeting stroke volume, or to standard CVP-guided therapy.
- GDHT received less intraoperative IV fluid (1,385.0 ± 259.6 vs 1,958.0 ± 877.0 mL, p = 0.011), and rescue vasopressor use was 45% vs 100% (p = 0.001).
- The authors conclude GDHT safely limits fluid and vasopressor needs, while creatinine trajectories and delayed graft function (10%) were identical between groups.
- Randomized, blinded, two-center French superiority trial of 320 adults undergoing elective cardiac surgery with cardiopulmonary bypass.
- Patients received opioid-free anesthesia with ketamine, dexamethasone, lidocaine and magnesium, or opioid anesthesia with sufentanil.
- The 30-day composite of complications or death occurred in 75.4% versus 84.5% (RR 0.90; 95% CI 0.80 to 0.99; P = 0.049), with a fragility index of 1.
- The authors call the results hypothesis generating; cardiovascular and digestive complications and deaths were also lower with opioid-free anesthesia.
- A prospective randomized trial at a single tertiary university hospital enrolled 57 patients undergoing elective thoracotomy.
- Patients received preoperative ultrasound-guided paravertebral block or erector spinae plane block at T5 with 20 mL of 0.25% bupivacaine, with remifentanil titrated using the NOL index.
- Intraoperative remifentanil use was lower with PVB (431.4 vs 863.6 mcg, p < 0.001), as was 24-hour postoperative morphine (15.2 vs 20.1 mg, p = 0.002).
- Resting NRS scores were lower with PVB at 9 and 12 hours, and cough NRS scores were lower at all time points; the authors conclude ESPB may be insufficient for major thoracic surgery.
- Single-center, double-blind, placebo-controlled randomized trial of 70 adults with delayed recovery after on-pump cardiac surgery in Cairo, Egypt.
- Enteral levothyroxine (25-50 µg/d, titrated by body mass index) versus identical placebo, started on postoperative day 2 and continued until ICU discharge.
- The levothyroxine group had greater GCS improvement (aMD +7.81; 95% CI 5.24-10.38; p<0.001) and lower 30-day mortality (14.3% vs 45.7%; aHR 0.24; 95% CI 0.09-0.65; p=0.005).
- The authors call the mortality finding hypothesis-generating given only 21 events, and hospital stay was longer with levothyroxine (13.1 vs 10.3 days, p=0.005).
- Single-center randomized controlled study of 122 adults aged 60 or older with preoperative Anticholinergic Cognitive Burden scores of 3 or higher undergoing CABG.
- Patients given a deprescribing strategy that avoided perioperative anticholinergic anesthetic and analgesic drugs were compared with standard care that included them.
- At day 90, full Katz Index independence was more frequent with deprescribing (75.0% vs 41.1%, p < 0.001), and frailty scores were lower (median 3 vs 4, p < 0.001).
- Perioperative anticholinergic use was an independent predictor of 90-day total complications (OR 2.430, 95% CI 1.031-5.726, p = 0.042), and the authors call anticholinergic burden a modifiable risk factor.
- Randomized, double-blind, placebo-controlled multicenter trial of 80 patients from five French centers who met VA-ECMO weaning criteria.
- Patients received a single 24-hour levosimendan infusion or placebo; the primary endpoint was weaning failure, defined as no weaning within 48 h, another assist device, or death within 7 days.
- Weaning failure occurred in 25% of patients in both groups (OR 1.00, 95% CI 0.36 to 2.75; P = 1.00).
- Acute kidney injury at day 30 was more frequent with levosimendan (62.5% vs 38.5%; OR 2.67, 95% CI 1.08 to 6.62; P = 0.03), which the authors describe as hypothesis generating.
- Retrospective secondary analysis of a single-center randomized trial in 105 adults undergoing cardiac surgery with signs suggesting endothelial dysfunction.
- All patients received 80 ppm inhaled nitric oxide for 24 hours, then NO was given via cardiopulmonary bypass, mechanical ventilation, or nasal cannula, with metHb and uptake compared across these methods.
- Median metHb was 0.6% on bypass, 2.1% on ventilation, and 0.8% on nasal cannula; the metHb rise slope was steeper on ventilation than on bypass (β 8.354 * 10-3 vs 3.738 * 10-3, p < 0.001).
- Estimated NO delivery was higher on ventilation than on bypass (median 25.1 vs 8.2 μmol/min, p < 0.001), and the authors suggest metHb may help guide therapy when extrapulmonary effects are desired.
- Single-center randomized controlled trial in 50 children (general anesthesia alone) and 51 children (general anesthesia plus block), aged 4 to 12, undergoing thoracoscopic mediastinal tumor resection.
- General anesthesia alone was compared with general anesthesia plus a preincision, ultrasound-guided, single-level thoracic paravertebral block.
- 24-hour FLACC pain area under the curve was lower with the block: 41.3/240 vs 53.0/240, mean difference -11.8 (95% CI -14.2 to -9.34; p < 0.001).
- The authors also report higher QoR-15 scores at 24 hours, lower early pain scores, and reduced opioid use and hospital stay with the block.
- Predefined exploratory substudy of the GLORIOUS trial, including 878 adults undergoing nonemergent CABG and/or surgical aortic valve replacement at one tertiary center.
- Patients received restrictive (FiO2 50%) or liberal (FiO2 100%) oxygenation during bypass and the first hour after weaning; lung function was measured before and at 3 months.
- Pulmonary function fell across all measures at 3 months, such as FEV1 by 8.3 percentage points (95% CI 6.6 to 8.3), with no between-group differences (all p > 0.3).
- The authors concluded that restrictive oxygenation did not attenuate the decline and described the findings as hypothesis-generating.
- Double-blinded, placebo-controlled RCT at two Danish university hospitals, with 100 of 113 randomized patients undergoing non-emergent CABG analyzed.
- Surgeon-administered intraoperative sternal and chest wall infiltration with bupivacaine, epinephrine, clonidine, and dexamethasone (62.5 mL) was compared with saline placebo.
- No difference in opioid use over the first 24 postoperative hours: median 62.3 mg versus 64.0 mg oral morphine equivalents (p = 0.649).
- No secondary or safety endpoints differed significantly, and the authors concluded the intervention did not reduce opioid consumption or add clinical benefit.
- Ancillary analysis of a randomised trial of 66 adults undergoing cardiac surgery with expected prolonged cardiopulmonary bypass (over 90 min) at one French hospital.
- Patients were randomised to intra-operative haemo-adsorption or standard care, with endotoxin mass and activity measured from pre-surgery to 48 hours after surgery.
- Endotoxin mass fell after bypass while relative endotoxin activity rose, and high postoperative activity was linked to dobutamine requirement, inflammatory markers and organ injury; no effect sizes are reported in the abstract.
- The authors conclude that the capacity to inactivate endotoxin, rather than its quantity, may determine harm, and haemo-adsorption did not lower endotoxin mass or activity.
- Single-center RCT of 140 adults undergoing on-pump cardiac surgery, randomized 1:1 to flow-controlled or pressure-controlled ventilation.
- Individualized FCV with compliance-guided PEEP and driving pressure was compared with PCV using the same compliance-guided settings and tidal volumes of 6 to 8 ml/kg predicted body weight.
- Postoperative IL-8 at 6 h after bypass did not differ significantly (3.08 vs 3.60 pg/ml; β 0.08; 95% CI -0.17 to 0.33; P = 0.573), while mechanical power fell by 55% with FCV.
- Pulmonary and extrapulmonary complications were lower and hospital stay shorter with FCV, but these were explorative secondary outcomes that the authors say justify future trials.